TMEM14C

Transmembrane protein 14C · Q9P0S9 · TMEM14C on Sugi Atlas →

0 patent compounds predicted against TMEM14C, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to TMEM14C by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
The Effect of Protein on Calcium Absorption and Gastric Acid Production PHASE4COMPLETED
IMaging Della PLAcca Carotidea PHASE3COMPLETED
Modulation of GABA-A Receptors in Parkinson Disease-Flumazenil Arm PHASE1/PHASE2COMPLETED
[18F]-DPA-714 PET/CT (Positron Emission Tomography/Computerized Tomography) in Triple Negative Breast Cancers PHASE2COMPLETED
Comparison of A New Technique of Measure of the Insulin Resistance By Scintigraphy With the Reference Technique PHASE2COMPLETED
[18F]MC225-PET in Neurodegenerative Disease PHASE1/PHASE2UNKNOWN
CHED - Congenital Hereditary Endothelial Dystrophy: New Paradigm Shift in Therapy Using Topical Eye Drops PHASE2UNKNOWN
Identification of a Biomarker Predictive of Evolution of Parkinson Disease PHASE2UNKNOWN
Normal Binding of R-[11C]PK11195 in Human Subjects PHASE1UNKNOWN
to Assess the Safety of Ga68-Dolacga Injection in Healthy Volunteers PHASE1COMPLETED
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. PHASE1UNKNOWN
A Safety Study Of A Single Vaginal Administration Of P2G12 Antibody In Healthy Female Subjects PHASE1COMPLETED
A Study to Assess the Pharmacokinetics of ASP015K in Healthy Male Subjects PHASE1COMPLETED
Imaging of Neuro-Inflammation and the Risk for Post-Traumatic Epilepsy PHASE1ACTIVE_NOT_RECRUITING
First Time in Human Study (FTIH) With Positron Emission Tomography (PET) PHASE1COMPLETED
Evaluation of Two Radioactive Chemicals to Image mGluR5 Receptors in Brain PHASE1COMPLETED
Assessment of [11C]ER176 to Image Translocator Protein in Brain and Whole Body of Healthy People EARLY_PHASE1COMPLETED
Study of Biodistribution, Metabolism, Excretion and Brain Uptake 18F-JSS20-183A EARLY_PHASE1RECRUITING
Multi-Tracer PET Quantitation of Skeletal Muscle Insulin Resistance in Type 2 Diabetes Mellitus nanCOMPLETED
Brain Inflammation in Major Depressive Disorder Background nanCOMPLETED
Brain P-gp and Inflammation in People With Epilepsy nanCOMPLETED
18F-Fluoride Positron Emission Tomography (PET) in Paget's Disease of Bone nanCOMPLETED
Understanding Factors That Influence Electronic Cigarette Nicotine Delivery Through PET Imaging of Beta-2 Nicotinic Acetylcholine Receptors nanWITHDRAWN
Preliminary Study for Identification of Calcium-Binding Proteins in the Serum in Various Metabolic Bone Disorders nanUNKNOWN
Radiation Dosimetry of the 18 kDa Translocator Protein Ligand [18F]PBR111 in Humans nanCOMPLETED
Pathogenesis of Acute Stress Induced (Tako-tsubo) Cardiomyopathy: Energy Shut-Down or Intense Inflammation? nanCOMPLETED
Validation of 3-[11C]-OHB nanCOMPLETED
Pharmacokinetics of Low Molecular Weight Heparin in Cancer Patients nanCOMPLETED
Prediction of Excretion and Toxicity of High Dose Methotrexate in Children and Adolescents With ALL nanCOMPLETED
Multi-Tracer PET Quantitation of Insulin Action in Muscle (Phase 1, Phase 2, Phase 3, Phase 4) nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a TMEM14C binder may also engage these)

ProteinNameSimilarity
Q5R751 1.000 Q5R751 →
Q9CQN6 1.000 Q9CQN6 →
Q3ZCI1 1.000 Q3ZCI1 →
Q0P436 0.998 Q0P436 →
Q924P2 0.997 Q924P2 →
Q9W1K0 0.995 Q9W1K0 →
Q9NUH8 0.989 Q9NUH8 →
A8MWL7 0.987 A8MWL7 →
Q9C6T7 0.984 Q9C6T7 →
O64847 0.981 O64847 →
Q75JB5 0.981 Q75JB5 →
Q9P7G3 0.980 Q9P7G3 →
P47131 0.979 P47131 →
Q9LJU6 0.977 Q9LJU6 →
B3LIC1 0.971 B3LIC1 →
A5DGY3 0.970 A5DGY3 →
A3LU53 0.968 A3LU53 →
B4UN04 0.967 B4UN04 →
C6CC69 0.967 C6CC69 →
O13113 0.967 O13113 →
A1JL11 0.967 A1JL11 →
Q6BXM0 0.967 Q6BXM0 →
B7NBD4 0.966 B7NBD4 →
B7NSY7 0.966 B7NSY7 →
Q321S6 0.966 Q321S6 →
C6CQK7 0.966 C6CQK7 →
A7FG53 0.966 A7FG53 →
Q1CK22 0.966 Q1CK22 →
Q5PHE0 0.966 Q5PHE0 →
A9R2H3 0.966 A9R2H3 →